OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Improving these processes involves fine-tuning various factors, including cell line development, media ingredients, and bioreactor environments. A key goal is to increase antibody production while lowering production